CRO News Fortrea and Omico Collaborate to Connect Genomically Profiled Patients With Biomarker-Led CRO Oncology Trials in Australia 23 October 2026
Content GreenLight Clinical and Taimei Technology Expand CRO Alliance to Enterprise-Wide AI Platform at AusBiotech 2026 23 October 2026
CRO News Marvel Biosciences Signs LOI With Novotech CRO for Phase 1 First-in-Human Trial of MB-204 in Australia 8 October 2026
CRO News Quantum BioPharma Signs Phase 2 Study Start-Up Agreement With Thermo Fisher’s PPD CRO for First-in-Class MS Candidate Lucid-MS 7 October 2026
CRO News CellCarta and Imagene AI Expand CRO Collaboration to Validate and Deploy AI-Powered Biomarker and CDx Programs With Leading Pharma Partners 2 October 2026
CRO News Emerald Clinical Trials Appoints Former Novotech COO Michael Stibilj as CEO to Lead Next Phase of Asia-Pacific CRO Growth 1 October 2026
CRO News BioToxTech Targets 200% Growth in U.S. and European Non-Clinical CRO Orders With Bundled Turnkey Package Model 30 September 2026
Ora Clinical Launches Clinical Intelligence Committee to Bring 14 Global Ophthalmology KOLs Into Real-Time CRO Development Decisions 25 September 2026
CRO News Parexel Launches FSP Integrated Solutions to Move Beyond Headcount-Based CRO Outsourcing With AI-Enabled Outcomes Model 24 September 2026
Content NanoImaging Services and Proteos Merge as TrueCourse Biosciences to Meet Demand for Wet-Lab Validation of AI-Designed Drugs 23 September 2026